Invention Grant
- Patent Title: Agonists of ROR GAMMAt
-
Application No.: US17610548Application Date: 2020-05-07
-
Publication No.: US12012374B2Publication Date: 2024-06-18
- Inventor: Lalgudi S. Harikrishnan , Muthoni G. Kamau , Brian E. Fink
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen
- International Application: PCT/US2020/031747 2020.05.07
- International Announcement: WO2020/231713A 2020.11.19
- Date entered country: 2021-11-11
- Main IPC: C07D207/12
- IPC: C07D207/12 ; C07C317/22 ; C07D401/06 ; C07D403/06 ; C07D407/06 ; C07D409/06 ; C07D417/06
Abstract:
The present invention is directed to compounds of the formula wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
Public/Granted literature
- US20230242478A1 AGONISTS OF ROR GAMMAt Public/Granted day:2023-08-03
Information query
